EPIGRAL — Epigral Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMid CapHigh Flyer

Annual income statement for Epigral, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,286	15,509	21,884	19,292	25,501
Cost of Revenue
Gross Profit	4,117	7,085	8,980	7,083	10,108
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	6,408	11,273	16,059	15,709	19,719
Operating Profit	1,878	4,237	5,825	3,583	5,782
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,609	3,834	5,225	2,908	5,411
Provision for Income Taxes
Net Income After Taxes	1,008	2,528	3,533	1,959	3,577
Net Income Before Extraordinary Items
Net Income	1,008	2,528	3,533	1,959	3,577
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,008	2,528	3,533	1,959	3,577
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	24.3	60.9	85	47.1	83.9
Dividends per Share